Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HEROLD

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
Biomed Research International|June 14, 2013
Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profilingW B Mattes, H G Kamp, E Fabian, et al.
Scientific Reports|January 24, 2024
Nuclear and mitochondrial genetic variants associated with mitochondrial DNA copy numberAdriana Koller, Michele Filosi, Hansi Weissensteiner, et al.
Journal of Cancer Research and Clinical Oncology|August 10, 2005
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)M Herold, A Schulze, D Niederwieser, et al.
Journal of the Royal Society, Interface|June 6, 2019
An architectural understanding of natural sway frequencies in treesT Jackson, A Shenkin, J Moore, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2015
Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)C Kahl, R Krahl, C Becker, et al.
Investigative Ophthalmology & Visual Science|January 14, 2026
The Association of Polygenic Risk Score With Glaucoma and Its Related Traits: Results From Two German Population-Based StudiesAnna M Welzel, Caroline Brandl, Janina M Herold, et al.
Annals of Hematology|August 1, 2020
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysisM Pouyiourou, A Meyer, A Stroux, et al.
Bone Marrow Transplantation|September 12, 2001
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimensM Deininger, W Pönisch, R Krahl, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 9, 2005
Chronomics, neuroendocrine feedsidewards and the recording and consulting of nowcasts--forecasts of geomagneticsR Jozsa, F Halberg, G Cornélissen, et al.
Surveys in Geophysics|August 10, 2019
The Importance of Consistent Global Forest Aboveground Biomass Product ValidationL Duncanson, J Armston, M Disney, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
Biomed Research International|June 14, 2013
Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profilingW B Mattes, H G Kamp, E Fabian, et al.
Scientific Reports|January 24, 2024
Nuclear and mitochondrial genetic variants associated with mitochondrial DNA copy numberAdriana Koller, Michele Filosi, Hansi Weissensteiner, et al.
Journal of Cancer Research and Clinical Oncology|August 10, 2005
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)M Herold, A Schulze, D Niederwieser, et al.
Journal of the Royal Society, Interface|June 6, 2019
An architectural understanding of natural sway frequencies in treesT Jackson, A Shenkin, J Moore, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2015
Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)C Kahl, R Krahl, C Becker, et al.
Investigative Ophthalmology & Visual Science|January 14, 2026
The Association of Polygenic Risk Score With Glaucoma and Its Related Traits: Results From Two German Population-Based StudiesAnna M Welzel, Caroline Brandl, Janina M Herold, et al.
Annals of Hematology|August 1, 2020
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysisM Pouyiourou, A Meyer, A Stroux, et al.
Bone Marrow Transplantation|September 12, 2001
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimensM Deininger, W Pönisch, R Krahl, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 9, 2005
Chronomics, neuroendocrine feedsidewards and the recording and consulting of nowcasts--forecasts of geomagneticsR Jozsa, F Halberg, G Cornélissen, et al.
Surveys in Geophysics|August 10, 2019
The Importance of Consistent Global Forest Aboveground Biomass Product ValidationL Duncanson, J Armston, M Disney, et al.
Pageof 28